Ahead of the Nataru Holiday Season, Phapros Increases Antimo Production by 43 Percent, Targeting 9 Percent Growth

JAKARTA, December 20, 2024 – PT Phapros Tbk, a national pharmaceutical company that has been established for seven decades, remains committed to providing quality health products for the Indonesian people. In anticipation of the 2024 Christmas and 2025 New Year (Nataru) holiday season, Phapros, through Antimo Group, is organizing a series of activities to support the comfort of travelers.

As part of this campaign, Antimo Group is hosting events at three strategic transportation hubs: Purabaya Terminal (Sidoarjo), Mangkang Terminal (Semarang), and Kampung Rambutan Terminal (Jakarta). The activities aim to educate transportation users on the importance of preventing motion sickness for comfort during the long holiday period.

In addition to on-site activities, Antimo Group is also conducting social media campaigns to reach a wider audience and strengthen public awareness in efforts to enhance travel comfort, especially during important moments like the Nataru holiday season.

“Through various initiatives, including collaborations with digital partners, we aim to ensure that Antimo products are not only recognized but also remain a trusted travel companion for the public. This is part of our ongoing efforts to adapt to the needs of the times and remain relevant to all segments of society,” said Acting Director of Phapros, Ida Rahmi Kurniasih, in an official statement on Tuesday, December 24, 2024.

From a business perspective, Phapros is optimistic about Antimo Group's performance in December 2024. Sales targets are projected to grow by nine percent compared to the previous month. To anticipate increased demand, Phapros has also increased Antimo tablet production by 43 percent compared to the previous month. This step was taken to ensure product availability remains stable across all distribution areas.

“We are confident that the nine percent sales growth target for December can be achieved through the various strategies we have implemented. With increased production and a more consumer-centric approach, we are certain that the public's need for a product that can make their holiday travel more comfortable—Antimo—will be well met during this holiday season,” he explained.

According to an internal survey conducted by Phapros at the beginning of the second semester of 2024, Antimo was the most consumed product by consumers, compared to other brands that only accounted for one percent, and 14 percent of respondents were loyal consumers of the motion sickness medication. The survey involved residents in the Jabodetabek area from various backgrounds, including office workers, entrepreneurs, housewives, doctors, nurses, and students.

“Antimo has been present in Indonesian society for 52 years, becoming a trusted product with the tagline 'Antimo, making your family's journey comfortable.' Based on the survey, it can be perceived that consumers have good loyalty toward Antimo, our legendary brand,” said Ida Rahmi Kurniasih.